New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 11, 2013
11:20 EDTDNB, DSX, FRX, KBR, GNK, MGAHigh option volumes; DNB DSX FRX KBR GNK MGA
News For DNB;DSX;FRX;KBR;GNK;MGA From The Last 14 Days
Check below for free stories on DNB;DSX;FRX;KBR;GNK;MGA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
16:08 EDTFRXActavis, Forest Labs receive second request under Hart-Scott-Rodino from FTC
Subscribe for More Information
07:33 EDTDNBD&B acquires Fliptop's social data matching business unit
Subscribe for More Information
April 15, 2014
05:59 EDTDSXScorpio, Diana Shipping trade well below NAV, says Deutsche Bank
Deutsche Bank says shares of Scorpio Bulkers (SALT) and Diana Shipping (DSX) are trading well below their net asset values following the recent pullback in the names. Deutsche points out that new and secondhand dry bulk asset prices have increased materially since the end of 2013. It reiterates Buy ratings on both stocks.
April 14, 2014
16:40 EDTGNKOZ Management reports 7.32% stake in Genco Shipping
OZ Management intends to monitor the company’s restructuring process, as first described in the Current Report on Form 8-K filed by the company with the SEC on April 3, with the intent of taking any and all actions that OZ Management deems necessary or appropriate to protect and/or maximize the value of their respective investments in the company's securities. Such actions may include, but are not limited to, entering into discussions with the Issuer, management and/or the board. OZ Management may consult with other holders of the company's securities regarding the Restructuring Process.
April 11, 2014
07:40 EDTMGAMagna price target raised to $110 from $93 at Morgan Stanley
Subscribe for More Information
April 10, 2014
09:25 EDTKBREngineering stocks could be boosted by gas exports, says Sterne Agee
Subscribe for More Information
April 9, 2014
10:06 EDTMGAOn The Fly: Analyst Upgrade Summary
AmSurg (AMSG) upgraded to Buy from Hold at Cantor... CBOE Holdings (CBOE) upgraded to Buy from Neutral at BofA/Merrill... Carlyle Group (CG) upgraded to Outperform from Perform at Oppenheimer... FireEye (FEYE) upgraded to Buy from Hold at Topeka... Fortune Brands (FBHS) upgraded to Outperform from Neutral at Credit Suisse... Gray Television (GTN) upgraded to Outperform from Market Perform at Wells Fargo... Hibbett Sports (HIBB) upgraded to Overweight from Neutral at Piper Jaffray... LinkedIn (LNKD) upgraded to Buy from Hold at Topeka... Mallinckrodt (MNK) upgraded to Buy from Neutral at UBS... NXP Semiconductors (NXPI) upgraded to Strong Buy from Outperform at Raymond James... Nexstar (NXST) upgraded to Outperform from Market Perform at Wells Fargo... Penn National (PENN) upgraded to Overweight from Equalweight at Barclays... Philip Morris (PM) upgraded to Neutral from Reduce at Nomura... SAIC (SAIC) upgraded to Market Perform from Underperform at Wells Fargo... Sinclair Broadcast (SBGI) upgraded to Outperform from Market Perform at Wells Fargo... Yelp (YELP) upgraded to Buy from Fair Value at CRT Capital... Danaher (DHR) upgraded to Strong Buy from Buy at ISI Group... Quanex (NX) upgraded at BB&T... Omnicell (OMCL) upgraded at Craig-Hallum... Volkswagen (VLKAY) upgraded to Outperform from Market Perform at Bernstein... Magna (MGA) upgraded to Neutral from Sell at Citigroup... Actavis (ACT) upgraded to Positive from Neutral at Susquehanna... E-Trade (ETFC) upgraded to Neutral from Underperform at BofA/Merrill... AmerisourceBergen (ABC) upgraded to Outperform from Market Perform at FBR Capital... CONSOL (CNX) upgraded to Outperform from Neutral at Macquarie.
08:49 EDTKBRKBR names Stuart Bradie as CEO
Subscribe for More Information
08:20 EDTMGAMagna upgraded to Neutral from Sell at Citigroup
Subscribe for More Information
05:50 EDTFRXForest Labs reports FDA provided feedback on combination aclidinium, formoterol
Forest Laboratories announced that they have recently received feedback from the FDA regarding the fixed dose combination of aclidinium and formoterol. Although no new issues have arisen, further discussion is needed with the Agency in order to address questions related to CMC, or Chemistry, Manufacturing and Control, and a Type C meeting with the FDA is going to be requested, likely to be held during Q3 this year. Forest and Almirall believe that the fixed dose combination of aclidinium and formoterol can be an important therapy for U.S. COPD patients.
April 7, 2014
11:05 EDTGNK High option volume stocks: EXC QCOR SQQQ GNK PPG
Subscribe for More Information
09:03 EDTMGAMagna expands Dortec manufacturing facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use